SAIMA USMANI

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NEWARK, NJ NPI 1669933800

General Payments — all program years on this page

$391.24

  • Category: General Payments
  • Program years: PY2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $391.24 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $391.2422

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $391.2422

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078365457 Janssen Biotech, Inc. $15.51 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087440510 Novartis Pharmaceuticals Corporation $22.44 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087440512 Novartis Pharmaceuticals Corporation $16.30 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087440518 Novartis Pharmaceuticals Corporation $18.21 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092263960 Boston Scientific Corporation $15.62 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104834131 Biogen, Inc. $24.50 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106262258 ABBVIE INC. $15.58 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106262260 ABBVIE INC. $15.55 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110778911 Eisai Inc. $18.24 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118997195 Otsuka America Pharmaceutical, Inc. $19.30 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137954470 Merz Pharmaceuticals, LLC $18.26 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142120217 ARGENX US, INC. $17.85 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143511552 UCB, Inc. $17.70 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145657486 Neurelis, Inc. $16.66 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145657488 Neurelis, Inc. $15.94 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145977321 Lundbeck LLC $18.34 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150226605 JAZZ PHARMACEUTICALS INC. $17.64 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150858457 Neurocrine Biosciences, Inc. $20.10 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150863219 Neurocrine Biosciences, Inc. $18.73 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151598681 Teva Pharmaceuticals USA, Inc. $15.65 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154115449 SK Life Science, Inc. $19.40 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154809358 Life Molecular Imaging Ltd $13.72 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.